BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eccles LJ, Bell AC, Powell SN. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks. DNA Repair (Amst) 2018;64:1-9. [PMID: 29459202 DOI: 10.1016/j.dnarep.2018.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Rominiyi O, Collis SJ. DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. Mol Oncol 2021. [PMID: 34036721 DOI: 10.1002/1878-0261.13020] [Reference Citation Analysis]
2 Barghouth PG, Karabinis P, Venegas A, Oviedo NJ. Poly(ADP-Ribose) Polymerase-3 Regulates Regeneration in Planarians. Int J Mol Sci 2020;21:E875. [PMID: 32013251 DOI: 10.3390/ijms21030875] [Reference Citation Analysis]
3 Landelouci K, Sinha S, Pépin G. Type-I Interferon Signaling in Fanconi Anemia. Front Cell Infect Microbiol 2022;12:820273. [DOI: 10.3389/fcimb.2022.820273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lozinski M, Bowden NA, Graves MC, Fay M, Tooney PA. DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets. Cell Oncol (Dordr) 2021. [PMID: 34057732 DOI: 10.1007/s13402-021-00613-0] [Reference Citation Analysis]
5 Cai M, Dunn CE, Chen W, Kochupurakkal BS, Nguyen H, Moreau LA, Shapiro GI, Parmar K, Kozono D, D’andrea AD. Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection. Cell Reports 2020;30:2402-2415.e5. [DOI: 10.1016/j.celrep.2020.01.052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
6 Ghosal K, Agatemor C, Han RI, Ku AT, Thomas S, Mukherjee S. Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance. Mini Rev Med Chem 2020;20:779-87. [PMID: 31902358 DOI: 10.2174/1389557520666200103114556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Badra Fajardo N, Taraviras S, Lygerou Z. Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.015] [Reference Citation Analysis]
8 Sharp MF, Bythell-Douglas R, Deans AJ, Crismani W. The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target. Mol Cell 2021;81:2278-89. [PMID: 33984284 DOI: 10.1016/j.molcel.2021.04.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hu C, Bugbee T, Gamez M, Wallace NA. Beta Human Papillomavirus 8E6 Attenuates Non-Homologous End Joining by Hindering DNA-PKcs Activity. Cancers (Basel) 2020;12:E2356. [PMID: 32825402 DOI: 10.3390/cancers12092356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Guitton-Sert L, Gao Y, Masson JY. Animal models of Fanconi anemia: A developmental and therapeutic perspective on a multifaceted disease. Semin Cell Dev Biol 2021;113:113-31. [PMID: 33558144 DOI: 10.1016/j.semcdb.2020.11.010] [Reference Citation Analysis]
11 Rodríguez A, Zhang K, Färkkilä A, Filiatrault J, Yang C, Velázquez M, Furutani E, Goldman DC, García de Teresa B, Garza-Mayén G, McQueen K, Sambel LA, Molina B, Torres L, González M, Vadillo E, Pelayo R, Fleming WH, Grompe M, Shimamura A, Hautaniemi S, Greenberger J, Frías S, Parmar K, D'Andrea AD. MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia. Cell Stem Cell 2021;28:33-47.e8. [PMID: 32997960 DOI: 10.1016/j.stem.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]